MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Cao, Zheng ^a,b   Moore, Benjamin T ^b   Wang, Yang ^b   Peng, Xian Hao ^b   Lappe, Joan M ^b   Recker, Robert R ^b   Xiao, Peng ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 422A; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN422 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BIOINFORMATICS; BONE DENSITY; CAUCASIAN; CBL GENE; CD226 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IGF1 GENE; MONOCYTE; OSTEOCLASTOGENESIS; PAG1 GENE; POSTMENOPAUSE OSTEOPOROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOB2 GENE; UPREGULATION; BIOLOGY; BLOOD; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY;

AGED; BASE SEQUENCE; BIOLOGICAL MARKERS; BONE DENSITY; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MIDDLE AGED; MONOCYTES; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 84901276445     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097098     Document Type: Article

References (40)

1. Manolagas SC (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115-137.
2. Arron JR, Choi Y (2000) Bone versus immune system. Nature 408: 535-536.
3. Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, et al. (2006) Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24: 33-63.
4. Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA (1996) The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137: 4058-4060.
5. Cohen-Solal ME, Graulet AM, Denne MA, Gueris J, Baylink D, et al. (1993) Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 77: 1648-1653.
6. Deng FY, Lei SF, Zhang Y, Zhang YL, Zheng YP, et al. (2011) Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans. Mol Cell Proteomics 10: M111.
7. Chen XD, Xiao P, Lei SF, Liu YZ, Guo YF, et al. (2010) Gene expression profiling in monocytes and SNP association suggest the importance of the STAT1 gene for osteoporosis in both Chinese and Caucasians. J Bone Miner Res 25: 339-355.
8. Liu YZ, Dvornyk V, Lu Y, Shen H, Lappe JM, et al. (2005) A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem 280: 29011-29016.
9. Ebert MS, Sharp PA (2012) Roles for microRNAs in conferring robustness to biological processes. Cell 149: 515-524.
10. Li Z, Hassan MQ, Volinia S, van Wijnen AJ, Stein JL, et al. (2008) A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 105: 13906-13911.
11. Hassan MQ, Gordon JA, Beloti MM, Croce CM, van Wijnen AJ, et al. (2010) A network connecting Runx2, SATB2, and the miR-23a-27a-24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A 107: 19879-19884.
12. Kapinas K, Kessler C, Ricks T, Gronowicz G, Delany AM (2010) miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J Biol Chem 285: 25221-25231.
13. Mizuno Y, Yagi K, Tokuzawa Y, Kanesaki-Yatsuka Y, Suda T, et al. (2008) miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 368: 267-272.
14. Inose H, Ochi H, Kimura A, Fujita K, Xu R, et al. (2009) A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci U S A 106: 20794-20799.
15. Li H, Xie H, Liu W, Hu R, Huang B, et al. (2009) A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 119: 3666-3677.
16. Sugatani T, Vacher J, Hruska KA (2011) A microRNA expression signature of osteoclastogenesis. Blood 117: 3648-3657.
17. Mizoguchi F, Izu Y, Hayata T, Hemmi H, Nakashima K, et al. (2010) Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption. J Cell Biochem 109: 866-875.
18. Sugatani T, Hruska KA (2009) Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem 284: 4667-4678.
19. Bae Y, Yang T, Zeng HC, Campeau PM, Chen Y, et al. (2012) miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 21: 2991-3000.
20. Kagiya T, Nakamura S (2012) Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation. J Periodontal Res 48: 373-85.
21. Nakasa T, Shibuya H, Nagata Y, Niimoto T, Ochi M (2011) The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis. Arthritis Rheum 63: 1582-1590.
22. Cheng P, Chen C, He HB, Hu R, Zhou HD, et al. (2013) miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res 28: 1180-1190.
23. Wang Y, Li L, Moore BT, Peng XH, Fang X, et al. (2012) MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS One 7: e34641.
24. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531.
25. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
26. Faltejskova P, Svoboda M, Srutova K, Mlcochova J, Besse A, et al. (2012) Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med 16: 2655-2666.
27. Wang P, Fu T, Wang X, Zhu W (2010) Primary, study of miRNA expression patterns in laryngeal carcinoma by microarray. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24: 535-538.
28. Gougelet A, Pissaloux D, Besse A, Perez J, Duc A, et al. (2011) Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer 129: 680-690.
29. Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L (2012) Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 39: 6219-6225.
30. Song KH, Li T, Owsley E, Chiang JY (2010) A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes. J Lipid Res 51: 2223-2233.
31. Bidzhekov K, Gan L, Denecke B, Rostalsky A, Hristov M, et al. (2012) microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost 107: 619-625.
32. Palmieri A, Pezzetti F, Brunelli G, Martinelli M, Lo ML, et al. (2008) Peptide-15 changes miRNA expression in osteoblast-like cells. Implant Dent 17: 100-108.
33. Kim JH, Kim K, Jin HM, Song I, Youn BU, et al. (2010) Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1. J Biol Chem 285: 5224-5231.
34. Kakehi S, Nakahama K, Morita I (2007) Expression and possible role of PVR/CD155/Necl-5 in osteoclastogenesis. Mol Cell Biochem 301: 209-217.
35. Matsubara T, Ikeda F, Hata K, Nakanishi M, Okada M, et al. (2010) Cbp recruitment of Csk into lipid rafts is critical to c-Src kinase activity and bone resorption in osteoclasts. J Bone Miner Res 25: 1068-1076.
36. Ajima R, Akiyama T, Usui M, Yoneda M, Yoshida Y, et al. (2008) Osteoporotic bone formation in mice lacking tob2; involvement of Tob2 in RANK ligand expression and osteoclasts differentiation. FEBS Lett 582: 1313-1318.
37. Gillberg P, Olofsson H, Mallmin H, Blum WF, Ljunghall S, et al. (2002) Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men. Calcif Tissue Int 70: 22-29.
38. Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, et al. (1998) Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83: 4257-4262.
39. Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, et al. (2006) Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Calcif Tissue Int 78: 18-24.
40. Crane JL, Cao X (2013) Function of matrix IGF-1 in coupling bone resorption and formation. J Mol Med 92: 107-115.